Structure Solves the Problem with Malaria Merozoite Vaccines
- PMID: 31623952
- PMCID: PMC11131090
- DOI: 10.1016/j.pt.2019.09.004
Structure Solves the Problem with Malaria Merozoite Vaccines
Abstract
Malaria vaccines targeting merozoite invasion of erythrocytes have long held appeal but failed in clinical trials. Three structural studies of antibody-antigen complexes by Alanine et al., Urusova et al., and Rawlinson et al. define neutralizing and nonneutralizing epitopes in essential invasion proteins, leading to rational design of improved merozoite vaccines.
Keywords: Plasmodium falciparum; Plasmodium vivax; X-ray crystallography; epitopes; malaria vaccine; neutralizing antibody.
Published by Elsevier Ltd.
Comment on
-
Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP.Nat Microbiol. 2019 Sep;4(9):1486-1496. doi: 10.1038/s41564-019-0461-2. Epub 2019 May 27. Nat Microbiol. 2019. PMID: 31133752 Free PMC article.
-
Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody.Nat Microbiol. 2019 Sep;4(9):1497-1507. doi: 10.1038/s41564-019-0462-1. Epub 2019 May 27. Nat Microbiol. 2019. PMID: 31133755 Free PMC article.
-
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.Cell. 2019 Jun 27;178(1):216-228.e21. doi: 10.1016/j.cell.2019.05.025. Epub 2019 Jun 13. Cell. 2019. PMID: 31204103 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical